Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Journal of cardiovascular translational research - 1 Oct 2018

Tan Shi Hua, Ye Lei

Abstract excerpt

Cardiomyocytes derived from human pluripotent stem cells (hPSCs) are emerging as an invaluable alternative to primarily sourced cardiomyocytes. The potentially unlimited number of hPSC-derived cardiomyocytes (hPSC-CMs) that may be obtained in vitro facilitates high-throughput applications like cell transplantation for myocardial repair, cardiotoxicity testing during drug development, and patient-specific disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiotoxicity
Share to Cardiovascular Agents
Share to Cell Lineage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Myocytes, Cardiac

Share to Pluripotent Stem Cells

Share to Stem Cell Transplantation

Share to Toxicity Tests

Source

Identifiers

PMID: 29557052
DOI: 10.1007/s12265-018-9801-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.PMID 29557052Read ↗

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytesSemantic proximity Read ↗

Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations.Semantic proximity Read ↗

Concise Review: Maturation Phases of Human Pluripotent Stem Cell-Derived CardiomyocytesSemantic proximity Read ↗

Metabolic Maturation in hiPSC-Derived Cardiomyocytes: Emerging Strategies for Inducing the Adult Cardiac PhenotypeSemantic proximity Read ↗

Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?Semantic proximity Read ↗

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.Semantic proximity Read ↗

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived CardiomyocytesSemantic proximity Read ↗

Cardiomyocyte Maturation-the Road is not Obstructed.Semantic proximity Read ↗

Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspectsSemantic proximity Read ↗

Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytesSemantic proximity Read ↗

Advancements in cardiac regenerative therapy: Scalable human iPSC-derived cardiomyocyte differentiation and maturationSemantic proximity Read ↗

Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.